Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Post by cromanon Jan 10, 2012 7:26pm

286 Views

Post# 19388882

NICE RUN,,,,,,,,

Nice run to date, wondering if it will continue.

Allthough I apply T/A for most of my investments, I normanlly dont give T/A much wieght when it comes to penny stocks. The T/A on this puppy is getting into the overbought area. Is there more steam for another day?

Some news would help

Lets see what happens tomorrow.

Croman

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources